Evolus

Update in progress

EOLS (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Evolus, Inc. is a performance beauty company that sells cash-pay aesthetic products in the United States, Canada, Europe, and Australia. It offers Jeuveau, a purified botulinum toxin type A formulation for temporarily reducing moderate to severe glabellar lines in adults, and Evolysse, a line of hyaluronic acid gel fillers for the midface, nasolabial folds, lips, and around the eyes. The company was founded in 2012 and is headquartered in Newport Beach, California.

Company score

Sentiment: 0.31; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive

Company

MarketNasdaqGM (NGM)
LocationUnited States
CEOMr. David Moatazedi
Founded2012
Employees353
Websitewww.evolus.com

Identifiers

ISINUS30052C1071
FIGIBBG005CX4HK8
LEI549300VYQRYBQOT8V419
CUSIP30052C107
CIK0001570562